Literature DB >> 22859379

Use of cannabis enhances attentional inhibition.

Ana B Vivas1, Angeles F Estevez, Margarita Moreno, George Panagis, Pilar Flores.   

Abstract

OBJECTIVE: Orienting attention to an irrelevant location hampers the response to subsequent targets presented at that location in relation to novel, not previously attended, locations. This inhibitory effect has been named inhibition of return. We conducted an experiment to study the temporal course of inhibition of return in users of cannabis.
METHOD: Twenty-five cannabis users who self-reported a regular frequency of cannabis use in joints per month, and 26 drug-free controls participated in the study. We employed a typical inhibition of return task with a single cue and manipulated the time interval between the onset of the cue and the target (150, 350, 550, 1500, and 2550 ms). Participants were asked to detect the onset of the target regardless of its location.
RESULTS: The group of cannabis users showed a significantly greater overall inhibition relative to the group of nonusers. Furthermore, inhibition of return appeared earlier (at the 350 ms cue-target interval) in the user group.
CONCLUSIONS: This is the first study to show that attentional inhibition is enhanced in cannabis users. More research is needed to determine whether greater inhibition represents an advantage or disadvantage for visual search performance of cannabis users.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22859379     DOI: 10.1002/hup.2248

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  2 in total

Review 1.  [Clinical prognosis of schizophrenic patients with cannabis addiction. Between nihilism and hope].

Authors:  T Schnell
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

2.  Does Chronic Cannabis Use Impact Risky Decision-Making: An Examination of fMRI Activation and Effective Connectivity?

Authors:  David R Raymond; Adrian Paneto; Karmen K Yoder; Brian F O'Donnell; Joshua W Brown; William P Hetrick; Sharlene D Newman
Journal:  Front Psychiatry       Date:  2020-11-27       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.